Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance

Third quarter 2026 revenue of $21.6 million, representing 65% growth year-over-yearFull year 2026 revenue guidance raised to $78 million to $80 millionCARLSBAD, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. NASDAQ:CARL (“Carlsmed” or the “Company”), a medical technology company pioneerin…